POWER PAK HEAVY DUTY DAIRY CLEANER Australië - Engels - APVMA (Australian Pesticides and Veterinary Medicines Authority)

power pak heavy duty dairy cleaner

delaval pty ltd - chlorine present as sodium dichloroisocyanurate; sodium hydroxide - powder - chlorine present as sodium dichloroisocyanurate mineral-chlorine active 38.0 g/kg; sodium hydroxide mineral-sodium-base active 586.0 g/kg - dairy cleanser - milking equipment | milking machine - residue, dirt in milking equipment

DELAVAL CHLORTECH HEAVY DUTY DAIRY CLEANER Australië - Engels - APVMA (Australian Pesticides and Veterinary Medicines Authority)

delaval chlortech heavy duty dairy cleaner

delaval pty ltd - chlorine present as sodium dichloroisocyanurate; sodium hydroxide - soluble powder - chlorine present as sodium dichloroisocyanurate mineral-chlorine active 38.0 g/kg; sodium hydroxide mineral-sodium-base active 586.0 g/kg - dairy cleanser - milking equipment | milking machine - residue, dirt in milking equipment

REMOVAL BOMB LOW FOAM DAIRY DETERGENT Australië - Engels - APVMA (Australian Pesticides and Veterinary Medicines Authority)

removal bomb low foam dairy detergent

ruakura pty limited - alkaline salts; chlorine present as sodium dichloroisocyanurate; sodium hydroxide - soluble powder - alkaline salts cleanser/sanitiser active 330.0 g/kg; chlorine present as sodium dichloroisocyanurate mineral-chlorine active 23.6 g/kg; sodium hydroxide mineral-sodium-base active 620.0 g/kg - dairy cleanser - dairy plant stainless steel | milking equipment | building | milking machine - milkstone removal | residue, dirt in milking equipment | milk fat | milk protein | mineral deposits

PROPAFENONE HCL- propafenone hydrochloride tablet, film coated Verenigde Staten - Engels - NLM (National Library of Medicine)

propafenone hcl- propafenone hydrochloride tablet, film coated

mckesson corporation dba sky packaging - propafenone hydrochloride (unii: 33xch0hocd) (propafenone - unii:68iqx3t69u) - propafenone hydrochloride 150 mg - propafenone hydrochloride is indicated to: - prolong the time to recurrence of paroxysmal atrial fibrillation/flutter (paf) associated with disabling symptoms in patients without structural heart disease. - prolong the time to recurrence of paroxysmal supraventricular tachycardia (psvt) associated with disabling symptoms in patients without structural heart disease. - treat documented ventricular arrhythmias, such as sustained ventricular tachycardia that, in the judgment of the physician, are life-threatening. initiate treatment in the hospital. usage considerations: - the use of propafenone hydrochloride tablets in patients with permanent atrial fibrillation (af) or in patients exclusively with atrial flutter or psvt has not been evaluated. do not use propafenone hydrochloride tablets to control ventricular rate during af. - some patients with atrial flutter treated with propafenone have developed 1:1 conduction, producing an increase in ventricular rate. concomitant treatment with drugs that increase the 

PROPAFENONE HCL- propafenone hydrochloride tablet, film coated Verenigde Staten - Engels - NLM (National Library of Medicine)

propafenone hcl- propafenone hydrochloride tablet, film coated

a-s medication solutions - propafenone hydrochloride (unii: 33xch0hocd) (propafenone - unii:68iqx3t69u) - propafenone hydrochloride 225 mg - propafenone hydrochloride is indicated to: - prolong the time to recurrence of paroxysmal atrial fibrillation/flutter (paf) associated with disabling symptoms in patients without structural heart disease. - prolong the time to recurrence of paroxysmal supraventricular tachycardia (psvt) associated with disabling symptoms in patients without structural heart disease. - treat documented ventricular arrhythmias, such as sustained ventricular tachycardia that, in the judgment of the physician, are life-threatening. initiate treatment in the hospital. usage considerations: - the use of propafenone hydrochloride tablets in patients with permanent atrial fibrillation (af) or in patients exclusively with atrial flutter or psvt has not been evaluated. do not use propafenone hydrochloride tablets to control ventricular rate during af. - some patients with atrial flutter treated with propafenone have developed 1:1 conduction, producing an increase in ventricular rate. concomitant treatment with drugs that increase the 

PROPAFENONE HYDROCHLORIDE- propafenone hydrochloride tablet, film coated Verenigde Staten - Engels - NLM (National Library of Medicine)

propafenone hydrochloride- propafenone hydrochloride tablet, film coated

a-s medication solutions - propafenone hydrochloride (unii: 33xch0hocd) (propafenone - unii:68iqx3t69u) - propafenone hydrochloride 225 mg - propafenone hydrochloride tablets are indicated to: usage considerations: propafenone hydrochloride tablets are contraindicated in the following circumstances: pregnancy category c. there are no adequate and well-controlled studies in pregnant women. propafenone hydrochloride tablets should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. animal data: teratogenic effects: propafenone has been shown to be embryotoxic (decreased survival) in rabbits and rats when given in oral maternally toxic doses of 150 mg/kg day (about 3 times the maximum recommended human dose [mrhd] on a mg/m2 basis) and 600 mg/kg/day (about 6 times the mrhd on a mg/m2 basis), respectively. although maternally tolerated doses (up to 270 mg/kg/day, about 3 times the mrhd on a mg/m2 basis) produced no evidence of embryotoxicity in rats, post-implantation loss was elevated in all rabbit treatment groups (doses as low as 15 mg/kg/day, about 1/3 the mrhd on a mg/m2 basis). non-teratogenic

DRIVER NON-IONIC SURFACTANT Australië - Engels - APVMA (Australian Pesticides and Veterinary Medicines Authority)

driver non-ionic surfactant

dksh agrisolutions pty ltd - alcohol alkoxylate & free fatty acids - liquid - alcohol alkoxylate & free fatty acids emulsifiers & surfactants active 870.0 g/l - wetting agent - aerial spraying | broadacre | fire fighting water | fungicide additive | general horticultural use | growth regulator additive | - reduction of dust | wetting agent (use as directed) | improve penetrating properties

DELAVAL PRECLEAN POST MILKING RINSE ADDITIVE Australië - Engels - APVMA (Australian Pesticides and Veterinary Medicines Authority)

delaval preclean post milking rinse additive

delaval pty ltd - non-ionic ethoxylate/s - liquid - non-ionic ethoxylate/s emulsifiers & surfactants-noni active 87.5 g/l - dairy cleanser - milking equipment | milking machine - residue, dirt in milking equipment

DAIRY POWER INLINE HEAVY DUTY ALKALI CLEANER-LOW FOAM Australië - Engels - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dairy power inline heavy duty alkali cleaner-low foam

ecolab pty ltd - non-ionic detergents; sodium hydroxide - soluble powder - non-ionic detergents emulsifiers & surfactants-noni active 9.0 g/kg; sodium hydroxide mineral-sodium-base active 800.0 g/kg - dairy cleanser - dairy equipment stainless steel | dairy plant stainless steel | building - residue, dirt in milking equipment

propafenone hcl- Propafenone Hydrochloride tablet, film coated Verenigde Staten - Engels - NLM (National Library of Medicine)

propafenone hcl- propafenone hydrochloride tablet, film coated

ethex - propafenone hydrochloride (unii: 33xch0hocd) (propafenone - unii:68iqx3t69u) - tablet, film coated - 150 mg - in patients without structural heart disease, propafenone hcl is indicated to prolong the time to recurrence of - paroxysmal atrial fibrillation/flutter (paf) associated with disabling symptoms. - paroxysmal supraventricular tachycardia (psvt) associated with disabling symptoms. as with other agents, some patients with atrial flutter treated with propafenone have developed 1:1 conduction, producing an increase in ventricular rate. concomitant treatment with drugs that increase the functional av refractory period is recommended. the use of propafenone in patients with chronic atrial fibrillation has not been evaluated. propafenone should not be used to control ventricular rate during atrial fibrillation. propafenone is also indicated for the treatment of initiation of propafenone treatment, as with other antiarrhythmics used to treat life-threatening ventricular arrhythmias, should be carried out in the hospital. propafenone, like other antiarrhythmic drugs, has not been shown to enhance survival in patients w